Literature DB >> 20226210

Procalcitonin levels in surgical patients at risk of candidemia.

Alvise Martini1, Leonardo Gottin, Nicola Menestrina, Vittorio Schweiger, Davide Simion, Jean-Louis Vincent.   

Abstract

OBJECTIVE: Although the majority of cases of sepsis in intensive care unit (ICU) patients are due to bacterial infection, fungal infections are common and their early identification is important so that appropriate treatment can be started. Biomarkers have been used to aid diagnosis of bacterial infections, but their role in fungal infections is less defined. In this study we assessed the value of procalcitonin (PCT) levels for the diagnosis of candidemia or bacteremia in septic patients.
METHODS: We prospectively recorded PCT levels in 48 critically ill surgical patients with signs of sepsis and at high risk for fungal infection, and compared levels in patients with candidemia and bacteremia.
RESULTS: Bacterial species were isolated from blood cultures in 16 patients, Candida species in 17, and mixed bacterial and Candida species in 2 patients. PCT levels were less elevated in patients with candidemia (median 0.71 [IQR 0.5-1.1]) than in those with bacteremia (12.9 [2.6-81.2]). A PCT value less than 2 ng/ml enabled bacteremia to be ruled out with a negative predictive value of 94%, and had a similar positive predictive value for candidemia.
CONCLUSIONS: Our data indicate that a low PCT value in a critically ill septic patient is more likely to be related to candidemia than to bacteremia. Copyright (c) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20226210     DOI: 10.1016/j.jinf.2010.03.003

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  21 in total

1.  Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Authors:  Helena Brodská; Karin Malíčková; Václava Adámková; Hana Benáková; Markéta Marková Šťastná; Tomáš Zima
Journal:  Clin Exp Med       Date:  2012-05-27       Impact factor: 3.984

Review 2.  Bloodstream infections in the Intensive Care Unit.

Authors:  Matteo Bassetti; Elda Righi; Alessia Carnelutti
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

Review 3.  [Invasive candidiasis in non-neutropenic adults : Guideline-based management in the intensive care unit].

Authors:  A Glöckner; O A Cornely
Journal:  Anaesthesist       Date:  2013-12       Impact factor: 1.041

4.  The role of procalcitonin in neonatal intensive care unit patients with candidemia.

Authors:  Maria Teresa Montagna; Caterina Coretti; Antonella Rella; Giovanna Barbuti; Fabio Manca; Osvaldo Montagna; Nicola Laforgia; Giuseppina Caggiano
Journal:  Folia Microbiol (Praha)       Date:  2012-06-12       Impact factor: 2.099

5.  Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit.

Authors:  Filippo Pieralli; Lorenzo Corbo; Arianna Torrigiani; Dario Mannini; Elisa Antonielli; Antonio Mancini; Francesco Corradi; Fabio Arena; Alberto Moggi Pignone; Alessandro Morettini; Carlo Nozzoli; Gian Maria Rossolini
Journal:  Intern Emerg Med       Date:  2017-02-04       Impact factor: 3.397

6.  Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients.

Authors:  Markéta Marková; Helena Brodská; Karin Malíčková; Veronika Válková; Petr Cetkovský; Michal Kolář; Martin Haluzík
Journal:  Support Care Cancer       Date:  2013-05-28       Impact factor: 3.603

7.  Comparison of (1->3)-β-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia.

Authors:  Jürgen Held; Isabelle Kohlberger; Elfriede Rappold; Andrea Busse Grawitz; Georg Häcker
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

Review 8.  Role of biomarkers in sepsis care.

Authors:  Ravi S Samraj; Basilia Zingarelli; Hector R Wong
Journal:  Shock       Date:  2013-11       Impact factor: 3.454

Review 9.  Bloodstream infections in internal medicine.

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

10.  Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study.

Authors:  Sari Karlsson; Milja Heikkinen; Ville Pettilä; Seija Alila; Sari Väisänen; Kari Pulkki; Elina Kolho; Esko Ruokonen
Journal:  Crit Care       Date:  2010-11-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.